Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CellSeed EuropeR.L.

Request full access

CellSeed develops regenerative medicine products primarily in Japan and Europe

Basel, SwitzerlandFounded 2001Biotech & Life Sciences

About CellSeed EuropeR.L.

CellSeed Inc., established in May 2001, is a Japanese firm operating in the regenerative medicine sector. The company leverages a proprietary technology known as "Cell Sheet Engineering," which was developed by Professor Teruo Okano at Tokyo Women's Medical University. This technology utilizes temperature-responsive polymers to culture and harvest cells in sheet form without the need for enzymes that can damage the tissue. The current President and CEO is Setsuko Hashimoto, Ph.D.

The company's business model is centered on the commercialization of regenerative medicine products and related services. It operates through two main segments: the Cell Sheet Regenerative Medicine Business and the Cell Cultureware Business. The regenerative medicine arm focuses on developing treatments for conditions like esophageal and knee cartilage damage. Clinical trials for an epithelial cell sheet for esophageal regeneration began in Japan in 2016. The firm is also advancing allogeneic chondrocyte sheets for knee osteoarthritis, with a Phase 3 clinical trial notification submitted in September 2023.

CellSeed's revenue is generated through multiple streams. A significant part comes from providing Contract Development and Manufacturing Organization (CDMO) services to research institutions and biotech firms. For instance, they manufacture autologous chondrocyte sheets for Tokai University's Advanced Medical Care B program. Another income source is the sale of their specialized cell cultureware, such as the UpCell®, RepCell®, and HydroCell® product lines, to researchers globally. The company collaborates with research institutes and seeks global distribution partners for its laboratory ware. CellSeed was listed on the JASDAQ market in 2010 and transitioned to the Tokyo Stock Exchange's Growth Market in 2022.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2014
Open positions
None listed
Dealroom signal
22.7/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, Horizon Europe, DT and LS, science-based, Swiss DT Biotech
Business model
Manufacturing
Client focus
B2B
Links
Website

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO EQUITY✓Other financing Mar 2014 $3.9M — Whiz Partners —
IPO✓Exit Jan 2014 $0 — Undisclosed —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

CellSeed EuropeR.L. website traffic

Latest recorded traffic for CellSeed EuropeR.L. is 12K monthly website visits, down 7.7% over the last three months.

Latest monthly visits12K 3-month web change-7.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

CellSeed EuropeR.L. in the Basel ecosystem

Live from Dealroom

The CellSeed EuropeR.L. office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Whiz Partners

Other known investors3 additional known investors

  • Fast Track Initiative
  • Nippon Venture Capital
  • Nissay Capital
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇭 Switzerland · Basel HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about CellSeed EuropeR.L. on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CellSeed EuropeR.L.’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.